Leibniz Prize for Hans-Reimer Rodewald (DKFZ)
Hans-Reimer Rodewald of the German Cancer Research Center receives the Gottfried Wilhelm Leibniz Prize 2019, the most important research award in Germany. Rodewald’s research revolves around the question of how the different types of immune cells develop from stem cells and together form a functional defence system.
Hans-Reimer Rodewald © DKFZ/Jutta Jung
“We warmly congratulate Hans-Reimer Rodewald on this outstanding award, which he deserves to the highest degree. He has long impressed experts with his groundbreaking results, which contribute to a better understanding of the body’s defence system. With his excellent and methodologically innovative research into the basics of immune defence, he is also paving the way for the development and improvement of immune therapies against cancer,” said Michael Baumann, director of the DKFZ.
Complete Press Release (in German).